Centurium Capital
Beijingcenturium.com
Overview
Centurium Capital is a private equity firm that focuses on control or significant minority stakes in companies within the consumer, business services, healthcare, and technology sectors in China.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Accro Bioscience Inc. | May 2026 | Series C | Co-investor |
| Excalipoint Therapeutics | Mar 2026 | Seed | Lead |
| Genebox | Nov 2025 | Series B | Co-investor |
| Neolix | Oct 2025 | Series D | Co-investor |
| Iluvatar CoreX | Jan 2024 | Series D | Co-investor |
Key People
Shaoqiang Liu
Partner, Managing Director
Joey ZHANG
Director of Investor Relations
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
